182 related articles for article (PubMed ID: 16999220)
1. Eicosanoids and the vascular endothelium.
Egan K; FitzGerald GA
Handb Exp Pharmacol; 2006; (176 Pt 1):189-211. PubMed ID: 16999220
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology of selective inhibition of COX-2.
Grosser T
Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913
[TBL] [Abstract][Full Text] [Related]
3. Role of prostacyclin in the cardiovascular response to thromboxane A2.
Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
[TBL] [Abstract][Full Text] [Related]
4. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis.
Badimon L; Vilahur G; Rocca B; Patrono C
Cardiovasc Res; 2021 Jul; 117(9):2001-2015. PubMed ID: 33484117
[TBL] [Abstract][Full Text] [Related]
5. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase pathways.
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Acta Biochim Pol; 2014; 61(4):639-49. PubMed ID: 25343148
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.
Majed BH; Khalil RA
Pharmacol Rev; 2012 Jul; 64(3):540-82. PubMed ID: 22679221
[TBL] [Abstract][Full Text] [Related]
8. Biomedicine. Back to an aspirin a day?
Vane JR
Science; 2002 Apr; 296(5567):474-5. PubMed ID: 11964462
[No Abstract] [Full Text] [Related]
9. COX-2 inhibitors and metabolism of essential fatty acids.
Das UN
Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin among prostanoids.
Gryglewski RJ
Pharmacol Rep; 2008; 60(1):3-11. PubMed ID: 18276980
[TBL] [Abstract][Full Text] [Related]
11. The effect of NSAIDs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemiologic data.
García Rodríguez LA
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S41-4. PubMed ID: 11695251
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
Penglis PS; Cleland LG; Demasi M; Caughey GE; James MJ
J Immunol; 2000 Aug; 165(3):1605-11. PubMed ID: 10903770
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase inhibition and thrombogenicity.
Catella-Lawson F; Crofford LJ
Am J Med; 2001 Feb; 110 Suppl 3A():28S-32S. PubMed ID: 11173047
[TBL] [Abstract][Full Text] [Related]
14. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies.
Tapiero H; Ba GN; Couvreur P; Tew KD
Biomed Pharmacother; 2002 Jul; 56(5):215-22. PubMed ID: 12199620
[TBL] [Abstract][Full Text] [Related]
16. Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model.
Doroudi R; Gan LM; Selin Sjögren L; Jern S
Biochem Biophys Res Commun; 2000 Mar; 269(1):257-64. PubMed ID: 10694510
[TBL] [Abstract][Full Text] [Related]
17. Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin.
Ruan KH; Deng H; So SP
Biochemistry; 2006 Nov; 45(47):14003-11. PubMed ID: 17115695
[TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandins in pregnancy-induced hypertension.
Satoh K; Seki H; Sakamoto H
Am J Kidney Dis; 1991 Feb; 17(2):133-8. PubMed ID: 1899531
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase.
Davidge ST; Baker PN; Laughlin MK; Roberts JM
Circ Res; 1995 Aug; 77(2):274-83. PubMed ID: 7614714
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors.
Eskildsen MP; Hansen PB; Stubbe J; Toft A; Walter S; Marcussen N; Rasmussen LM; Vanhoutte PM; Jensen BL
Hypertension; 2014 Sep; 64(3):551-6. PubMed ID: 24914192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
